These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8252474)

  • 1. Loxiglumide (CR1505), a cholecystokinin antagonist, specifically inhibits the growth of human pancreatic cancer lines xenografted into nude mice.
    Nio Y; Tsubono M; Morimoto H; Kawabata K; Masai Y; Hayashi H; Manabe T; Imamura M; Fukumoto M
    Cancer; 1993 Dec; 72(12):3599-606. PubMed ID: 8252474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of a cholecystokinin antagonist, loxiglumide (CR-1505), on the growth of freshly separated and xenografted human pancreatic cancer.
    Morimoto H; Nio Y; Tsubono M; Tseng CC; Kawabata K; Masai Y; Hayashi H; Baba N; Manabe T; Hosokawa Y
    J Surg Oncol; 1993 May; 53(1):47-53. PubMed ID: 8386784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of UFT and loxiglumide (CR1505) on liver metastasis of human pancreatic cancer cell line, KP-1 N in nude mice].
    Shimazoe T; Funakoshi A; Kono A
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1321-5. PubMed ID: 1503487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
    Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
    Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
    Niederau C; Liddle RA; Williams JA; Grendell JH
    Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of combined use of CR1505 with UFT for the tumor growth of the subcutaneously transplanted pancreatic cancer in the Syrian golden hamsters].
    Tomioka M; Miyazaki N; Yamamoto M; Saito Y
    Nihon Shokakibyo Gakkai Zasshi; 1993 Mar; 90(3):693-9. PubMed ID: 8515583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of CR1505, a CCK antagonist, on pancreatic growth in hamsters].
    Tasi Y; Baba N; Nishimura I; Manabe T; Tobe T
    Nihon Shokakibyo Gakkai Zasshi; 1991 Apr; 88(4):1097-104. PubMed ID: 1857003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion.
    Adler G; Reinshagen M; Koop I; Göke B; Schafmayer A; Rovati LC; Arnold R
    Gastroenterology; 1989 Apr; 96(4):1158-64. PubMed ID: 2647576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term CCK stimulation and CCK blockade on pancreatic and intestinal growth, morphology, and function.
    Niederau C; Lüthen R; Niederau M; Strohmeyer G; Ferrell LD; Grendell JH
    Digestion; 1990; 46 Suppl 2():217-25. PubMed ID: 2262055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effect of lorglumide on pancreatic growth stimulated by camostate in rat and hamster.
    Douglas BR; Woutersen RA; Jansen JB; Rovati LC; Lamers CB
    Life Sci; 1990; 46(4):281-6. PubMed ID: 2304371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas.
    Dembinski A; Jaworek J; Konturek PK; Konturek SJ; Warzecha Z
    J Physiol; 1989 Apr; 411():419-35. PubMed ID: 2614728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the synthetic trypsin inhibitor camostate on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters.
    Meijers M; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
    Cancer Lett; 1991 Dec; 60(3):205-11. PubMed ID: 1756510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition of human pancreatic cancer cells by cholecystokinin receptor antagonist in tissue culture and in nude mice.
    Funakoshi A; Kono A
    Gastroenterol Jpn; 1992 Feb; 27(1):78-82. PubMed ID: 1555749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of cholecystokinin receptor antagonist (CR1505) on recovery of experimental pancreatitis after pancreatic duct occlusion in rats.
    Tomita H; Miyasaka K; Jimi A; Mishima Y; Funakoshi A
    Pancreas; 1994 Sep; 9(5):638-45. PubMed ID: 7809019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lorglumide and loxiglumide inhibit gastrin-stimulated DNA synthesis in a rat tumoral acinar pancreatic cell line (AR42J).
    Seva C; Scemama JL; Bastié MJ; Pradayrol L; Vaysse N
    Cancer Res; 1990 Sep; 50(18):5829-33. PubMed ID: 2393852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin antagonistic activities of loxiglumide.
    Wakatsuki K; Saito T; Saeki M; Ninomiya K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1997 Oct; 47(10):1130-3. PubMed ID: 9368707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin receptor antagonist, loxiglumide, inhibits invasiveness of human pancreatic cancer cell lines.
    Hirata M; Itoh M; Tsuchida A; Ooishi H; Hanada K; Kajiyama G
    FEBS Lett; 1996 Apr; 383(3):241-4. PubMed ID: 8925905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cholestyramine and cholecystokinin receptor antagonist CR1505 (loxiglumide) on lower esophageal sphincter pressure in man.
    Masclee AA; Jansen JB; Rovati LC; Lamers CB
    Dig Dis Sci; 1993 Oct; 38(10):1889-92. PubMed ID: 8404410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proglumide antagonizes cholecystokinin effects on plasma glucose and insulin in rats in vivo.
    Verspohl EJ; Wunderle G; Ammon HP
    Eur J Pharmacol; 1988 Jul; 152(1-2):121-8. PubMed ID: 3208828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of L-364,718, a new cholecystokinin receptor antagonist, on camostate-induced growth of the rat pancreas.
    Wisner JR; McLaughlin RE; Rich KA; Ozawa S; Renner IG
    Gastroenterology; 1988 Jan; 94(1):109-13. PubMed ID: 3335282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.